Artificial intelligence
fromFast Company
6 hours agoYou can't recall AI like a defective drug
The pharmaceutical regulatory model is inadequate for AI governance because AI risks differ fundamentally from pharmaceutical risks in ways that make traditional oversight frameworks insufficient for existential threats.